Skip to main content
SpringerLink
Log in

Moxonidine: A New Centrally Acting Antihypertensive

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Opie LH. Drugs 44 (Suppl. 1): 147–155, 1992

    Article  PubMed  Google Scholar 

  2. Chrisp P, Faulds D. Drugs 44: 993–1012, 1992

    Article  PubMed  CAS  Google Scholar 

  3. Ernsberger P, et al. J Pharmacol Exp Ther 253: 408–418, 1990

    PubMed  CAS  Google Scholar 

  4. Tibiriça E, et al. J Pharmacol Exp Ther 256: 606–613, 1991

    PubMed  Google Scholar 

  5. Simpson FO. In Avery’s Drug Treatment, 3rd ed., pp. 676–731, ADIS Press Ltd., Auckland, 1987

    Google Scholar 

  6. Plänitz V. J Clin Pharmacol 27: 46–51, 1987

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moxonidine: A New Centrally Acting Antihypertensive. Drugs Ther. Perspect 1, 4–6 (1993). https://doi.org/10.2165/00042310-199301080-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199301080-00002

Keywords

Search

Navigation